Volume 31, Number 9—September 2025
Research
Theileria luwenshuni and Novel Babesia spp. Infections in Humans, Yunnan Province, China
Table 1
Characteristics of 18 patients hospitalized for Theileria luwenshuni and Babesia spp. infection, China*
Characteristic | T. luwenshuni cases, n = 13 | Babesia spp. cases, n = 5 |
---|---|---|
Age, y (IQR) |
40 (32.5–68.0) |
56 (25.5–59.5) |
Sex | ||
M | 10 (77) | 4 (80) |
F |
3 (23) |
1 (20) |
Length of hospital stay, d (IQR) | 13 (7.5–17.0) | 10 (5.5–10.5) |
Occupation as farmer |
13 (100) |
5 (100) |
Medical history and underlying disease | ||
Renal failure | 5 (38) | 1 (20) |
Cancer | 3 (23) | 0 |
Upper gastrointestinal bleeding |
5 (38) |
3 (60) |
Clinical manifestations† | ||
Nonspecific symptoms | ||
Dizziness | 3 (23) | 4 (80) |
Malaise | 5 (38) | 4 (80) |
Cough | 1 (8) | 0 |
Jaundice | 1 (8) | 0 |
Splenomegaly | 1 (8) | 0 |
Weight loss | 1 (8) | 0 |
Cardiovascular manifestations | ||
Chest discomfort | 1 (8) | 1 (20) |
Palpitations | 3 (23) | 1 (20) |
Dyspnea | 2 (15) | 1 (20) |
Gastrointestinal manifestations | ||
Anorexia | 8 (62) | 2 (40) |
Vomiting | 4 (31) | 0 |
Bloating | 1 (8) | 1 (20) |
Stomachache | 1 (8) | 0 |
Hematemesis | 3 (23) | 0 |
Melena | 4 (31) | 3 (60) |
Neurologic manifestations | ||
Syncope | 1 (8) | 1 (20) |
Listlessness |
8 (62) |
2 (40) |
Laboratory findings | ||
Anemia | 13 (100) | 5 (100) |
Leukocytosis | 2 (15) | 1 (20) |
Elevated serum AST or ALT or γ-GGT concentration | 1 (8) | 0 |
*Values are no. (%) patient except as indicated. ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GGT, gamma-glutamyl transferase; IQR, interquartile range. †Patients could report >1 symptom.
1These authors contributed equally to this article.
Page created: July 17, 2025
Page updated: August 26, 2025
Page reviewed: August 26, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.